title: Differential expression of collagen, MMP, TIMP and fibrogenic-cytokine genes in the granulomatous colon of Schistosoma mansoni-infected mice.
abstract: Schistosomiasis mansoni is a major helminthic disease of the tropics characterised by chronic hepatic and intestinal granulomatous inflammation and fibrosis. The fibrotic response is regulated by the amount of collagen deposited in the tissues and the degradation of that collagen by matrix metalloproteinases (MMP). In the murine model of the disease, although hepatic granuloma formation and the ensuing fibrosis have been thoroughly examined, there is a dearth of information on the intestinal fibrotic process. The expression of fibrosis-related genes in the colons of chronically infected mice has therefore been investigated. Compared with that seen in uninfected mice, the expression of the genes coding for collagen of types I, III and IV was upregulated. Similarly, the messages for MMP-2, MMP-3 and MMP-8 were elevated, indicating the potential for collagen degradation. The genes for two tissue inhibitors of metalloproteinases (TIMP), TIMP-1 and TIMP-4, were, however, expressed at higher levels than those coding for the MMP. As a corollary, expression of the genes coding for three fibrogenic cytokines, transforming growth factor-beta, tumour necrosis factor and interleukin-4, was elevated. These data indicate that an imbalance in MMP:TIMP expression and enhanced levels of the messages for fibrogenic cytokines underlie the mechanism(s) of the colonic fibrosis seen in mice chronically infected with Schistosoma mansoni.
authors.affiliation: Department of Immunology and Microbiology, Wayne State University School of Medicine, 540 East Canfield Avenue, Detroit, MI 48201, USA.
authors.forename: K P
authors.initials: KP
authors.lastname: Singh
authors.forename: H C
authors.initials: HC
authors.lastname: Gerard
authors.forename: A P
authors.initials: AP
authors.lastname: Hudson
authors.forename: D L
authors.initials: DL
authors.lastname: Boros
mesh_terms: D000818:Animals; D002908:Chronic Disease; D003094:Collagen / Q000235:genetics*; D003106:Colon / Q000737:chemistry* / Q000473:pathology; D003108:Colonic Diseases / Q000235:genetics; D016207:Cytokines / Q000235:genetics*; D004195:Disease Models, Animal; D005260:Female; D005355:Fibrosis / Q000235:genetics; D017238:Genes, Helminth / Q000235:genetics; D006099:Granuloma / Q000235:genetics; D007082:Ileum / Q000737:chemistry / Q000473:pathology; D015847:Interleukin-4 / Q000235:genetics; D020782:Matrix Metalloproteinases / Q000235:genetics*; D051379:Mice; D008808:Mice, Inbred CBA; D012555:Schistosomiasis mansoni / Q000235:genetics*; D019714:Tissue Inhibitor of Metalloproteinases / Q000235:genetics*; D016212:Transforming Growth Factor beta / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics; D015854:Up-Regulation / Q000235:genetics
chemical_list: D016207:Cytokines; D019714:Tissue Inhibitor of Metalloproteinases; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D015847:Interleukin-4; D003094:Collagen; D020782:Matrix Metalloproteinases